BSXCongressional Stock Trades
Boston Scientific Corp.
Surgical & Medical Instruments & Apparatus
Congressional stock trades in Boston Scientific Corp. (BSX) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.
Total Trades
39
Politicians Trading
10
Last Traded
Aug 18, 2026
Trading History
| Politician | Notified | Traded | Type | Amount | Change |
|---|---|---|---|---|---|
| Gilbert Ray Cisneros, Jr.D | Sep 10, 2026 | Aug 18, 2026 | Buy | $1,001 - $15,000 | -14.13% |
| Ro KhannaD | Sep 4, 2026 | Aug 10, 2026 | Buy | $1,001 - $15,000 | -14.11% |
| Ro KhannaD | Sep 4, 2026 | Aug 3, 2026 | Buy | $1,001 - $15,000 | -10.51% |
| Ro KhannaD | Aug 7, 2026 | Jul 20, 2026 | Buy | $1,001 - $15,000 | -0.98% |
| Ro KhannaD | Jul 6, 2026 | Jun 30, 2026 | Buy | $1,001 - $15,000 | +1.55% |
| Ro KhannaD | Jul 6, 2026 | Jun 2, 2026 | Buy | $1,001 - $15,000 | -9.10% |
| Gilbert Ray Cisneros, Jr.D | Jul 2, 2026 | Jun 5, 2026 | Buy | $1,001 - $15,000 | -10.73% |
| Ro KhannaD | Jun 9, 2026 | May 15, 2026 | Buy | $1,001 - $15,000 | -17.73% |
| Gilbert Ray Cisneros, Jr.D | Mar 9, 2026 | Feb 10, 2026 | Buy | $1,001 - $15,000 | -41.63% |
| Gilbert Ray Cisneros, Jr.D | Feb 13, 2026 | Jan 30, 2026 | Buy | $1,001 - $15,000 | -53.66% |
| Gilbert Ray Cisneros, Jr.D | Dec 15, 2025 | Nov 18, 2025 | Buy | $1,001 - $15,000 | -56.32% |
| Lisa C. McClainR | Nov 21, 2025 | Oct 30, 2025 | Buy | $1,001 - $15,000 | -56.91% |
| Gilbert Ray Cisneros, Jr.D | Nov 18, 2025 | Oct 17, 2025 | Buy | $1,001 - $15,000 | -56.33% |
| Bruce WestermanR | Apr 16, 2025 | Mar 3, 2025 | Buy | $1,001 - $15,000 | -58.67% |
Price History
About Boston Scientific Corp.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.